Lineweaver Wealth Advisors, LLC Amgen Inc Transaction History

Lineweaver Wealth Advisors, LLC

$496 Million
Q3 2024

A detailed history of Lineweaver Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Lineweaver Wealth Advisors, LLC holds 1,189 shares of AMGN stock, worth $323,538. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,189

Previous 1,172 1.45%

Holding current value

$323,538

Previous $366,000 4.64%

% of portfolio

0.08%

Previous 0.08%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$309.38 - $337.38 $5,259 - $5,735	17 Added 1.45%	1,189 $383,000
Q2 2024 Aug 01, 2024	SELL	$262.75 - $319.31 $104,049 - $126,446	-396 Reduced 25.26%	1,172 $366,000
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $2,419 - $2,921	9 Added 0.58%	1,568 $445,000
Q4 2023 Jan 19, 2024	SELL	$255.7 - $288.46 $11,762 - $13,269	-46 Reduced 2.87%	1,559 $449,000
Q3 2023 Oct 19, 2023	BUY	$218.65 - $271.46 $40,450 - $50,220	185 Added 13.03%	1,605 $431,000
Q2 2023 Jul 26, 2023	SELL	$214.27 - $253.37 $9,642 - $11,401	-45 Reduced 3.07%	1,420 $315,000
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $8,580 - $10,457	38 Added 2.66%	1,465 $354,000
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $7,099 - $9,021	-31 Reduced 2.13%	1,427 $0
Q3 2022 Nov 01, 2022	SELL	$224.46 - $253.15 $673 - $759	-3 Reduced 0.21%	1,458 $328,000
Q2 2022 Jul 26, 2022	BUY	$230.71 - $256.74 $8,074 - $8,985	35 Added 2.45%	1,461 $355,000
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $10,305 - $11,400	-47 Reduced 3.19%	1,426 $345,000
Q4 2021 Jan 31, 2022	SELL	$198.88 - $227.6 $29,633 - $33,912	-149 Reduced 9.19%	1,473 $331,000
Q3 2021 Oct 22, 2021	BUY	$212.27 - $248.7 $7,853 - $9,201	37 Added 2.33%	1,622 $344,000
Q2 2021 Jul 26, 2021	BUY	$233.58 - $259.14 $16,117 - $17,880	69 Added 4.55%	1,585 $386,000
Q1 2021 Apr 30, 2021	BUY	$221.91 - $258.6 $31,289 - $36,462	141 Added 10.25%	1,516 $377,000
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $9,087 - $10,822	42 Added 3.15%	1,375 $316,000
Q3 2020 Oct 20, 2020	BUY	$234.65 - $260.95 $60,539 - $67,325	258 Added 24.0%	1,333 $338,000
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $212,645 - $260,945	1,075 New	1,075 $253,000

Others Institutions Holding AMGN

# of Institutions

3,097

Shares Held

406M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lineweaver Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lineweaver Wealth Advisors, LLC with notifications on news.

Account

Lineweaver Wealth Advisors, LLC Amgen Inc Transaction History